ng-nitroarginine methyl ester has been researched along with Bone Cancer in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baamonde, A; García, V; Hidalgo, A; Juárez, L; Menéndez, L | 1 |
| Akedo, H; Higashiyama, M; Horai, T; Iwasaki, T; Kuriyama, K; Matsuda, H; Mukai, M; Sasaki, A; Shinkai, K | 1 |
2 other study(ies) available for ng-nitroarginine methyl ester and Bone Cancer
| Article | Year |
|---|---|
Involvement of nitric oxide in the inhibition of bone cancer-induced hyperalgesia through the activation of peripheral opioid receptors in mice.
Topics: Analysis of Variance; Animals; Bone Neoplasms; Carbazoles; Dose-Response Relationship, Drug; Drug Administration Routes; Drug Interactions; Enzyme Activation; Enzyme Inhibitors; Glyburide; Hyperalgesia; Indoles; Loperamide; Mice; Mice, Inbred C3H; Naloxone; Narcotic Antagonists; NG-Nitroarginine Methyl Ester; Nitrates; Nitric Oxide; Nitrites; Pain Measurement; Receptors, Opioid | 2007 |
NG-nitro-L-arginine methyl ester inhibits bone metastasis after modified intracardiac injection of human breast cancer cells in a nude mouse model.
Topics: Animals; Bone Neoplasms; Breast Neoplasms; Female; Heart; Humans; Male; Mice; Mice, Inbred ICR; Mice, Nude; NG-Nitroarginine Methyl Ester; Radiography; Stereoisomerism; Transplantation, Heterologous; Transplantation, Heterotopic | 1997 |